Type One Diabetes Completed Phase 1 Trials for Insulin degludec (DB09564)

Back to Type One Diabetes

Also known as: Diabetes Mellitus, Juvenile-Onset / T1DM - Type 1 Diabetes Mellitus / Diabetes Type I / Type I Diabetes / Type1 Diabetes / Diabetes Type One / Diabete Type 1 / Type One Diabetes Mellitus / Diabetics Mellitus Type 1 / Type 1 Diabetes / Type 1 Diabetes Mellitus (T1DM) / Insulin-Dependent Diabetes Mellitus 1 / Type1diabetes / Diabetes Mellitus Type I / Type1 Diabetes Mellitus / Type 1 Diabetes (T1D) / Diabetes Mellitus Type 1 / Juvenile Onset Diabetes Mellitus / Diabetes Type 1 / Type 1 Insulin-Dependent Diabetes Mellitus / Type I Diabetes Mellitus / Diabetes Mellitus, Sudden-Onset / Type-1 Diabetes Mellitus / Insulin Dependent Diabetes Mellitus 1 / Type 1 Diabetes Mellitus / Juvenile-Onset Diabetes / Diabetes Mellitus, Insulin-Dependent, 1 / Diabetes mellitus type 1 (disorder) / Diabetes mellitus: [juvenile] or [insulin dependent] / Juvenile diabetes / Insulin dependent diabetic / IDDM / Diabetes mellitus insulin-dependent / Insulin-dependent diabetes mellitus / Diabetes mellitus juvenile onset / Immune-mediated diabetes / Insulin dependent diabetes mellitus / Insulin dependent diabetes mel / IDDM - Insulin-dependent diabetes mellitus / Diabetes mellitus - juvenile / Ketosis-prone diabetes mellitus (disorder) / Ketosis-prone diabetes mellitus

Indication	Status	Phase
DBCOND0076728 (Type One Diabetes)	Completed	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT06685185	A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes	Treatment	Insulin degludec (DB09564) Insulin detemir (DB01307) NNC0363-1063 (DB26327)
NCT02536859	Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus	Treatment	Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT01865318	Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes	Treatment	Insulin degludec (DB09564)
NCT01590836	A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT01138488	A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT01114542	A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 Diabetes	Treatment	Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT01030926	A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes	Treatment	Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT00993096	Investigation of the Response Relationship of NN5401 in Type 1 Diabetics	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT00964418	A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes	Treatment	Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT04569994	A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes	Treatment	Insulin degludec (DB09564) NNC0363-0845 (DB29350)
NCT01868529	Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus	Treatment	Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT01865292	Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes	Treatment	Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT01002768	Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics	Treatment	Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT01174303	A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT00964964	A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics	Treatment	Insulin degludec (DB09564)
NCT01051102	Effect of NN5401 in Japanese Subjects With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT01865279	Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec	Treatment	Insulin degludec (DB09564) Insulin human (DB00030)
NCT01773798	A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT01865305	Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT00992537	Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT01455142	A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT01704417	A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine	Treatment	Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT01076634	Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes	Treatment	Insulin degludec (DB09564)
NCT00961324	A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 Diabetes	Treatment	Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT01173926	Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT01135927	A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes	Treatment	Insulin degludec (DB09564) Insulin detemir (DB01307)
NCT03400501	Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin	Treatment	Degludec (DB22807) Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT01868568	Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)